drugset / Trial / NCT00170508

Young Adult Influenza Vaccine Immunogenicity Substudy

NCT00170508

Non-randomizedSingle-groupOpen-labelPrevention

Summary

This is a complimentary study to an elderly influenza study. Subjects 18-40 will receive a single dose flu vaccine and be evaluated for humoral and cell mediated immunity to influenza antigens.

Timeline

Start
2005-06
Primary completion
2005-08
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine 15 ug Intramuscular

Indications